Area of research
Genetics · Pediatrics, Perinatology and Child Health
Research interest
Research interests include Inflammatory Bowel Disease, Pharmaceutical studies and practices, Autoimmune and Inflammatory Disorders Research, and Gut microbiota and health.
Primary sclerosing cholangitis in children with inflammatory bowel disease: An ESPGHAN position paper from the Hepatology Committee and the IBD Porto group
Recurrence of Primary Sclerosing Cholangitis After Liver Transplant in Children: An International Observational Study
The Medical Management of Paediatric Crohn’s Disease: an ECCO-ESPGHAN Guideline Update
The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) Index: A Prognostic Tool for Children
Complicated Disease and Response to Initial Therapy Predicts Early Surgery in Paediatric Crohn’s Disease: Results From the Porto Group GROWTH Study
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: Predictors of Gamma Glutamyltransferase Normalization and Favorable Clinical Course
Outcomes of surgical management of familial intrahepatic cholestasis 1 and bile salt export protein deficiencies
Gamma Glutamyltransferase Reduction Is Associated With Favorable Outcomes in Pediatric Primary Sclerosing Cholangitis
The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration
Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHAN
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
Antibiotics Associated With Increased Risk of New-Onset Crohn’s Disease But Not Ulcerative Colitis: A Meta-Analysis
Outcome measures for clinical trials in paediatric IBD: an evidence-based, expert-driven practical statement paper of the paediatric ECCO committee
Faecal Calprotectin in Suspected Paediatric Inflammatory Bowel Disease
ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents
Loss of Interleukin-10 Signaling and Infantile Inflammatory Bowel Disease: Implications for Diagnosis and Therapy